Paradromics скачать в хорошем качестве

Paradromics

Summary The conversation delves into the use of neurotechnology to address the challenges faced by individuals with advanced forms of locked-in syndrome. It explores the limitations of traditional treatments and compares Paradromics' brain-computer interface with in-brain neuroelectronics. The functionality of microwire electrode arrays, signal processing, wireless telemetry, and machine learning algorithms for speech decoding are discussed, along with the challenges of existing communication methods for locked-in syndrome patients. The patent families and core technology of Paradromics' interface probe, as well as the comparison of platinum iridium microwire and thread systems, are also covered. Finally, the conversation addresses data compression and latency in speech decoding. The conversation delves into the competition between Neuralink and Paradromics, the importance of funding for companies like Paradromics, the leadership team behind Paradromics, financial considerations, costs and clinical trials, the target market and addressable population, device clearance and reimbursement, expansion into mental illness treatment, and competitors and industry advancements in the neurotech space. Takeaways Neurotech for Locked-In Syndrome Paradromics' Brain-Computer Interface Electrode Array Technology Neuralink and Paradromics are competitors in the brain-computer interface and neuro prosthetic space. Funding is crucial for companies like Paradromics to achieve clinical access, marketing, R&D, and partner institutions. Chapters 00:00 Introduction to Neurotech for Locked-In Syndrome 05:00 Comparison of Paradromics and In-Brain Neuroelectronics 09:51 Implantation and Functionality of Microwire Electrode Array 17:08 Machine Learning Algorithm for Speech Decoding 21:50 Patent Families and Core Technology of Paradromics' Interface Probe 29:01 Data Compression and Latency in Speech Decoding 36:24 The People Behind Paradromics 45:11 Target Market and Addressable Population 52:21 Expansion into Mental Illness Treatment